Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986; 140 (6); 543-546 Respiratory Syncytial Virus Infection (RSV): Infants and Young Children. Centers for Disease Control and Prevention. https://www.cdc.gov/rsv/high-risk/infants-young-children.html...
Centers for Disease Control and Prevention. RSV in Infants and Young Children. Available at:www.cdc.gov/rsv/high-risk/infants-young-children.html. AccessedMay 2024. Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due...
2. Zhang S, et al. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. J Infect Dis. 2020;222(Suppl 7):S680-687. 3. Hammitt LL, et al. Nirsevimab for Prevent...
16.Respiratory Syncytial Virus Infection (RSV): Infants and Young Children. Centers for Disease Control and Prevention. https://www.cdc.gov/rsv/high-risk/infants-young-children.html. Accessed September 2022. 17.Centers for Disease Control and ...
hospitals with sick children. RSV每年将成千上万的美国儿童送往医院。这种病毒对大多数健康人来说是一种类似感冒的疾病。但它可能危及生命在非常年轻和非常年老。去年,RSV病例大量增加,挤满了美国。有生病孩子的医院 The Food and Drug Administration (FDA) approved the injection for infants and children up to...
Centers for Disease Control and Prevention. RSV in Infants and Young Children. Available at:www.cdc.gov/rsv/high-risk/infants-young-children.html. AccessedMay 2024. Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due...
healthcare systems and pharmaceutical companies to work togethe r to ensure that all infants can benefit from the protection that nirsevimab affords. The road to combating RSV may have been long and arduous, but with nirsevimab, we are on the cusp of a new era in pediatric immunization.
RSV in Infants and Young Children. Centers for Disease Control and Prevention. December 18, 2020. https://www.cdc.gov/rsv/high-risk/infants-young-children.html Accessed December 2022. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (...
This is not the only option to protect infants from RSV. For years, pre-term infants have received antibodies that can help protect them from infection, but that was just for children considered vulnerable to the most serious kinds of infections. This year the FDA and CDC also approved an ...
RSV is a virus that attacks the lower lungs. In babies, who have tiny airways, RSV can cause the lungs to fill with mucus, making it difficult to breathe. It’s the leading cause of hospitalization in the United States for infants under 1 year of age. ...